FDAMAP

One stop source to highly informative conferences, workshops, and seminars for pharma, diagnostics & medical device industry professionals. Call [phone]

[FDAMAP @FDA_MAP]

As we welcome the New Year, we do so with gratitude and purpose.

At FDAMap, we believe progress is built through people—through trust, shared values, and partnerships that cross borders and cultures. From our FDAMap family to yours,
Happy New Year.

[FDAMAP @FDA_MAP]

Happy Holidays from FDAMap

As the year comes to a close, we’re grateful for the trust, integrity, and partnerships that drive our work. At FDAMap, we believe responsibly guided science has the power to improve lives.

Thank you for walking with us from complexity to clarity.

[FDAMAP @FDA_MAP]

FDAMap at the FTLA Summit Boston 2025
A powerful day of insight, innovation, and collaboration. From risk-to-solution roundtables to breakthrough ideas in biotech and compliance — we were proud to be part of it.
#FDAMap #FTLASummit #Biotech #Innovation #Leadership

[FDAMAP @FDA_MAP]

Don’t Let Regulatory Monsters Haunt Your Lab
🧪 Halloween Edition — by FDAMap

The scariest part of biotech isn’t in the lab — it’s in the regulations that follow.
From FDA submissions to GMP audits, unseen “monsters” can stall innovation.

[FDAMAP @FDA_MAP]

🪔 Happy Diwali from Dr. Mukesh Kumar & FDAMap!
May the light of knowledge, integrity, and compassion guide us forward.
Even the smallest flame can conquer darkness — keep shining your light. ✨

[FDAMAP @FDA_MAP]

✨ The work environment at FDA MAP is truly exceptional — and it shines even brighter during Diwali! 🌟
Grateful to be part of a team where professionalism, culture, and joy come together in perfect harmony.
#FDAMAP #DiwaliCelebration #TeamSpirit #InnovationWithHeart

[FDAMAP @FDA_MAP]

🚀 Discover FDA MAP – your global partner in regulatory strategy!
🧬 From clinical trials to FDA submissions, QA & training – we guide biotech, pharma & med devices from idea to market.
🌐 Led by Dr. Mukesh Kumar
👉 https://t.co/4xHjxe2Io9

[FDAMAP @FDA_MAP]

An Institutional Review Board (IRB) at Louisiana State University Health Science Center (LSUHSC) found to be non-compliant during a recent FDA audit. Learn more https://t.co/yH56iUYD7T

#FDA #fdacompliance #PatientSafety #clinicaltrial #fdaregulations #medicalresearch #Medicine

[FDAMAP @FDA_MAP]

Taxation and Clinical Trial Participation: The Hidden Obstacles
Should payments to patients participating in clinical trials be exempt from taxation?
https://t.co/WRSlUkg99e
#ClinicalTrials #PatientCare #FDA

[FDAMAP @FDA_MAP]

How Good Are New Drugs Compared to Previous Treatments? #drugdiscovery #DrugDevelopment #FDA #medicine #Pharmaceuticals #clinicaltrials #Health #healthcare #HealthcareInnovation #HealthcareChallenges #HealthTech Read More https://t.co/PEAXCyInpo

[FDAMAP @FDA_MAP]

GAO Evaluated Limitations of the FDA’s GCP Audits
#FDA #GCP #clinicaltrials #ClinicalResearch #Audit #USA #PatientCare #Compliance #regulation https://t.co/BcBGkHrvNx

[FDAMAP @FDA_MAP]

FDAMap has announced 5-Day Challenge program on Virtual Clinical Trials. Learn more about this challenge here https://t.co/xVv4FjbHVR
#clinicaltrials #clinicalstudies #clinicalresearch #FDA #patientsafety #medicalnews #HealthcareInnovation #healthcare

[FDAMAP @FDA_MAP]

Just posted a photo https://t.co/P1CdrNwM21

[FDAMAP @FDA_MAP]

Did @Biogen bribe doctors or play it fairly?

Read more - https://t.co/56qQQ3PWmo @ Washington D.C. https://t.co/zjO39B3xr2

[FDAMAP @FDA_MAP]

FDA Eases Compounding Rules for Hospitals: Ever So Slightly but Significantly

Read more at https://t.co/14rtEyyEJ3 @ Washington D.C. https://t.co/e0yaV5fiex

[FDAMAP @FDA_MAP]

FDA’s Publication Highlights How to Use/Not Use Precedent Information

Read more - https://t.co/Pl1GvWqZPD @ Washington D.C. https://t.co/L2XLIM22jz

[FDAMAP @FDA_MAP]

Just posted a photo https://t.co/XWzBVhncT5

[FDAMAP @FDA_MAP]

Just posted a photo @ Washington D.C. https://t.co/8x6K4OcEuF

[FDAMAP @FDA_MAP]

@anandcpatelmdms @JohnNosta That is incredibly accurate, the psychology behind free speech and correct information is quite interesting and in some cases, very damaging, especially in light of the pandemic.

[Matt Fisher @Matt_R_Fisher]

Have fair degree of skepticism around so many direct to #consumer #healthcare companies. Ro adding prescribing for #anxiety and #depression sounds like it could come with a lot of concerns. https://t.co/AH4CM1gzZ1